JESSICA GLENNIE: Open Payments
NPI 1467833848 · CLEVELAND, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,334 in 29 payments from 4 companies in 2025. Trend: 2023 $5,236 · 2024 $14,578 · 2025 $5,334
Consulting: $2,145Food & beverage: $1,340Travel & lodging: $968Speaker / faculty: $880
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 20 | $4,940 |
| United Therapeutics Corporation | 7 | $269 |
| AstraZeneca Pharmaceuticals LP | 1 | $97 |
| Regeneron Healthcare Solutions, Inc. | 1 | $28 |
Products named: FASENRA, OFEV, DUPIXENT, JASCAYD, Tyvaso.
Industry payments across OH — which companies pay providers there.
